Search
for
Sort by
Research 61–90 of 1000+
- Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Adipose stem cells isolated from diabetic mice improve cutaneous wound healing in streptozotocin-induced diabetic mice
- Hair, Cutaneous Homeostasis and Stem Cell Functions
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Lichen planopilaris
- Therapeutic Updates on Lichen planopilaris and Frontal Fibrosing Alopecia: A Systematic Review
- Medical comorbidities in patients with lichen planopilaris, a retrospective case–control study
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Lichen Planopilaris With Foreign-Body Granuloma
- Semaglutide and the Skin: An Overview of Current Evidence
- Clinical features of 109 patients with primary cicatricial alopecia: a 15-year retrospective study
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- The role of estrogen in cutaneous ageing and repair
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- A case series of 46 patients with lichen planopilaris: Demographics, clinical evaluation, and treatment experience
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
- Scalp Itch: A Systematic Review
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- [Prevalence of cutaneous lesions in Freixo de Espada à Cinta].
- Commentary: Treatment of lichen planopilaris
- Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin